BETA

Activities of Pernille WEISS related to 2022/2008(INI)

Plenary speeches (1)

Implementation of the Updated New Industrial Strategy for Europe: aligning spending to policy (debate)
2022/09/15
Dossiers: 2022/2008(INI)

Amendments (27)

Amendment 2 #
Motion for a resolution
Citation 8 a (new)
— having regard to the Commission communication of 25 November 2020 entitled ‘Pharmaceutical Strategy for Europe’,
2022/04/25
Committee: ITRE
Amendment 15 #
Motion for a resolution
Recital A a (new)
Aa. whereas the European Climate Law states that the Commission should facilitate sector-specific climate dialogues and partnerships by bringing together key stakeholders, so as to encourage sectors themselves to plan their transition towards achieving the Union’s climate-neutrality objective by 2050;
2022/04/25
Committee: ITRE
Amendment 22 #
Motion for a resolution
Recital B
B. whereas in a changing geopolitical world, reducing EU dependencies on critical materials, products and technologies, while fostering open trade and resilient global supply chains, is vital;
2022/04/25
Committee: ITRE
Amendment 40 #
Motion for a resolution
Recital C a (new)
Ca. whereas to realise its R&D potential, the EU must address the resilience of its supply chains while creating an attractive innovative high- value manufacturing and supply ecosystem;
2022/04/25
Committee: ITRE
Amendment 67 #
Motion for a resolution
Paragraph 1 a (new)
1a. Notes that in order to ensure a safe and prosperous life for our children and grandchildren, the EU must deliver on its ambitious climate targets; stresses that to succeed, the EU will have to take full advantage of all available technologies that support the green and digital transition including enabling technologies as well as promote innovation across the board; underlines in this regard that the EU should ensure technology neutrality and empower the whole spectrum of industry, from the small entrepreneur to the biggest of companies, to innovate and develop new ground-breaking technologies;
2022/04/25
Committee: ITRE
Amendment 76 #
Motion for a resolution
Paragraph 1 b (new)
1b. Welcomes the Commission’s communication entitled ‘Pharmaceutical Strategy for Europe’ and stresses that the strategy must also serve to support European competitiveness and resilience; recalls that the European life-science industry is of vital importance not only to patients but also to the European economy through its contribution to the positive EU trade balance and job creation within the ecosystem;
2022/04/25
Committee: ITRE
Amendment 78 #
Motion for a resolution
Paragraph 1 c (new)
1c. Calls on the Commission to strengthen the external competitiveness and resilience of the pharmaceutical industry in its upcoming revision the 'pharmaceutical legislation'1a and thus, in this regard, level the playing field for pharmaceutical innovation between EU and innovative third countries at the global level; _________________ 1a Directive 2001/83/EC of the European Parliament and of the Council of 6November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67) and Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1).
2022/04/25
Committee: ITRE
Amendment 82 #
Motion for a resolution
Paragraph 2
2. Underlines that the EU cannot be dependent on non-EU countries for products and technologies that are essential to our economy and for our society of the future; stresses the need to clearly define such dependencies and relevant market failures; stresses that the EU needs to regain a strong position in identified crucial global value chains and secure the supply of critical materials in times of crisis; this may be achieved by a number of different initiatives ranging from ensuring EU production to diversifying supply chains;
2022/04/25
Committee: ITRE
Amendment 108 #
Motion for a resolution
Paragraph 3
3. Calls on the Commission to present clear transition pathways for the industrial ecosystem as soon as possible, including by identifying the needs for aspecific market failures that hamper successful transition in terms of infrastructure, technologies and skills; calls on the Commission to ensure consistency and coordination across all initiatives, objectives, funding and regulatory instruments that will create the right framework conditions to support industry through the transitions; calls for annual monitoring and reporting on the competitiveness and resilience of our industrial ecosystems and on the progress made on the transition pathways, so that instruments can be adapted swiftly when needed;
2022/04/25
Committee: ITRE
Amendment 115 #
Motion for a resolution
Paragraph 3 a (new)
3a. Notes that the speed of the green and digital transition underlines the need for a well-functioning system for continuing education and training to secure competence development and adaptation through the entire work life;
2022/04/25
Committee: ITRE
Amendment 118 #
Motion for a resolution
Paragraph 3 b (new)
3b. Underlines that women are the largest untapped entrepreneurial potential; notes that women entrepreneurs receive less finance than men and that we need to strengthen the ecosystem; calls for the Commission to establish a gender- conscious investor network;
2022/04/25
Committee: ITRE
Amendment 131 #
Motion for a resolution
Paragraph 4 a (new)
4a. Calls on the Commission to ensure that all proposals under the Pharmaceutical Strategy for Europe should support the role of the EU as an innovator and world leader in pharmaceutical R&D; notes that attracting a strong research-based pharmaceutical industry to the EU will also support EU resilience;
2022/04/25
Committee: ITRE
Amendment 135 #
Motion for a resolution
Paragraph 4 b (new)
4b. Calls on the Commission to consider proposing regulatory sandboxes that allow innovation and experimentation within industrial sectors, such as bio-solutions, in areas where legislation is outdated or unfit, to ensure their fast access to market;
2022/04/25
Committee: ITRE
Amendment 141 #
Motion for a resolution
Paragraph 5
5. Calls on the Commission to close the investment gap with global competitors for key enabling technologies; welcomes, in this regard, the Commission’s proposal for a European Chips Act10 and the establishment of the European Alliance for Industrial Data, Edge and Cloud; calls on the Commission to extend these initiatives to key enabling technologies where market failures can be demonstrated, such as photonics and quantum; _________________ 10 COM(2022)0046.
2022/04/25
Committee: ITRE
Amendment 146 #
Motion for a resolution
Paragraph 5 a (new)
5a. Reminds the Commission that pharmaceutical exports make the largest contribution to the EU’s external trade surplus of any sector; underlines that a competitive and environmentally sustainable pharmaceutical industry in the EU is of strategic interest for economic growth, jobs, trade, and R&D and supports the goal of EU's 'open strategic autonomy';
2022/04/25
Committee: ITRE
Amendment 153 #
Motion for a resolution
Paragraph 6
6. Stresses the need to strengthen ‘Made in EU’ and accelerate the adoption of Industry 4.0 technologies, particularly by small and medium-sized enterprises (SMEs); calls on the Commission to embed the ‘Made in Europe’ partnership strongly in the Horizon Europe programme;
2022/04/25
Committee: ITRE
Amendment 167 #
Motion for a resolution
Paragraph 7
7. Welcomes the Commission’s announcement issuing guidance on public procurement; stresses that public procurement is an essential instrument for national and economic security and for supporting the uptake of and demand for clean and sustainable products; calls, in this regard, on the Commission to review public procurement and competition rules where needed;
2022/04/25
Committee: ITRE
Amendment 172 #
Motion for a resolution
Paragraph 7 a (new)
7a. Notes that for certain products, such as medicines, some public procurers tend to consider price as the sole criterion for procurement; stresses in this regard that consideration must be given to how guidance on public procurement can help support the uptake of products which are innovative, environmentally friendly, and which ensure security of supply and added value to patients; calls on the Commission to include guidance on the application of the Most Economic Advantageous Tender (MEAT) criteria in any updated guidelines on public procurement;
2022/04/25
Committee: ITRE
Amendment 183 #
Motion for a resolution
Paragraph 7 b (new)
7b. Stresses that joint public procurement of any products should not hinder access, innovation, consumer choice or competition;
2022/04/25
Committee: ITRE
Amendment 215 #
Motion for a resolution
Paragraph 10
10. Stresses the need for a future-proof regulatory framework and for regulatory stability and predictability; calls on the Commission to include roadmaps in the transition pathways to reduce administrative burdens for European businesses, especially SMEs, by at least 30 %; stresses the ‘one in, one out’ principle; stresses that the innovation principle should be reflected in all relevant legislative instruments and policies;
2022/04/25
Committee: ITRE
Amendment 223 #
Motion for a resolution
Paragraph 10 a (new)
10a. Recalls that a strong legislative intellectual property framework is essential to European competitiveness; calls on the Commission to ensure strong protection of intellectual property rights in the EU and beyond; recalls that incentives is the foundation for attracting investments in R&D, which support innovation for the benefit of citizens and the EU economy;
2022/04/25
Committee: ITRE
Amendment 226 #
Motion for a resolution
Paragraph 10 b (new)
10b. Stresses that to ensure competitive sustainability in industrial ecosystems, such as agri-food and life-science, the EU must promote a legislative framework characterised by efficient regulatory procedures and low administrative burdens; notes that fast-track approval procedures may in this regard be considered as initiatives beneficial to the green transition and EU competitiveness;
2022/04/25
Committee: ITRE
Amendment 227 #
Motion for a resolution
Paragraph 10 c (new)
10c. Notes that many industrial ecosystems would benefit from cross- sectoral EU strategies which support rapid development, fast market access and removal of regulatory barriers to the full deployment of sustainable solutions and enabling technologies;
2022/04/25
Committee: ITRE
Amendment 232 #
Motion for a resolution
Paragraph 11
11. Underlines the regional dimension of industrial policy and the role of regional smart specialisation strategies; calls on the Commission to include instruments to increase the use of ‘Made in EU’ at a regional level;
2022/04/25
Committee: ITRE
Amendment 249 #
Motion for a resolution
Paragraph 12 a (new)
12a. Supports the idea of an 'EU climate calculator' to assist industries in calculating the carbon and environmental footprint of products; Calls on the Commission to promote the use of ‘climate labelling’ of products based on climate calculations; recalls that this could serve as an effective antidote to 'green washing' and help bring down CO2 emissions; stresses that an 'EU climate calculator' should be based on life-cycle assessments;
2022/04/25
Committee: ITRE
Amendment 251 #
Motion for a resolution
Paragraph 12 b (new)
12b. Recalls the commitment by the Commission to facilitate sector-specific climate dialogues and partnerships in accordance with the European Climate Law; Urges the Commission to establish such climate partnerships as soon as possible within all industrial ecosystems, to plan their transition towards achieving the Union’s climate-neutrality objective by 2050;
2022/04/25
Committee: ITRE
Amendment 336 #
Motion for a resolution
Paragraph 21
21. Welcomes the European data spaces initiative; underlines the role that data spaces play for smart manufacturing; believes that the participation of non-EU companies in EU data space initiatives waters down the goal of strengthening the EU’s digital sovereignty;
2022/04/25
Committee: ITRE